Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7850)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Jul 28, 2016 (publication date) through Jun 9, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Åkerberg D, Ansari D, Andersson R. Re-evaluation of classical prognostic factors in resectable ductal adenocarcinoma of the pancreas. World J Gastroenterol 2016; 22(28): 6424-6433 [PMID: 27605878 DOI: 10.3748/wjg.v22.i28.6424] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v22/i28/6424.htm |
| Number | Citing Articles |
| 1 |
Anna Nurmi, Harri Mustonen, Helka Parviainen, Katriina Peltola, Caj Haglund, Hanna Seppänen. Neoadjuvant therapy offers longer survival than upfront surgery for poorly differentiated and higher stage pancreatic cancer. Acta Oncologica 2018; 57(6): 799 doi: 10.1080/0284186X.2017.1415458
|
| 2 |
Lingyu Zhu, Shuo Shen, Huan Wang, Guoxiao Zhang, Xiaoyi Yin, Xiaohan Shi, Suizhi Gao, Jiawei Han, Yiwei Ren, Jian Wang, Hui Jiang, Shiwei Guo, Gang Jin. A neoadjuvant therapy compatible prognostic staging for resected pancreatic ductal adenocarcinoma. BMC Cancer 2023; 23(1) doi: 10.1186/s12885-023-11181-x
|
| 3 |
Courtney J. Pokrzywa, Daniel E. Abbott, Kristina A. Matkowskyj, Sean M. Ronnekleiv-Kelly, Emily R. Winslow, Sharon M. Weber, Alexander V. Fisher. Natural History and Treatment Trends in Pancreatic Cancer Subtypes. Journal of Gastrointestinal Surgery 2019; 23(4): 768 doi: 10.1007/s11605-019-04113-3
|
| 4 |
Victor Rodrigues, Cristina Dopazo, Elizabeth Pando, Laia Blanco, Mireia Caralt, Concepción Gómez-Gavara, Itxarone Bilbao, María Teresa Salcedo, Joaquim Balsells, Ramon Charco. ¿Es realmente la afectación del ganglio de la arteria hepática un factor de mal pronóstico en el adenocarcinoma de páncreas?. Cirugía Española 2020; 98(4): 204 doi: 10.1016/j.ciresp.2019.09.015
|
| 5 |
Chihiro Sakugawa, Yukihiro Haruyama, Hiroyuki Tanaka, Tsuyoshi Fukushima, Makiko Kawaguchi, Hiroaki Kataoka. Prognostic significance of hepatocyte growth factor activator inhibitor type 1 (HAI-1) immunoreactivity in pancreatic ductal adenocarcinoma. BMC Research Notes 2017; 10(1) doi: 10.1186/s13104-017-3014-x
|
| 6 |
Si Shi, Xianjun Yu. Selecting chemotherapy for pancreatic cancer: Far away or so close?. Seminars in Oncology 2019; 46(1): 39 doi: 10.1053/j.seminoncol.2018.12.004
|
| 7 |
Mazlum ŞAHİN. Minimally invasive beating heart full coronary artery bypass in a patient with pancreatic ductal adenocarcinoma. The European Research Journal 2019; 5(5): 913 doi: 10.18621/eurj.431204
|
| 8 |
Anna-Katharina König, Hélène Gros, Ulf Hinz, Thomas Hank, Jörg Kaiser, Thilo Hackert, Frank Bergmann, Markus W. Büchler, Oliver Strobel. Refined prognostic staging for resected pancreatic cancer by modified stage grouping and addition of tumour grade. European Journal of Surgical Oncology 2022; 48(1): 113 doi: 10.1016/j.ejso.2021.07.020
|
| 9 |
Elisabeth S. Gruber, Gerd Jomrich, Dietmar Tamandl, Michael Gnant, Martin Schindl, Klaus Sahora, Francisco X. Real. Sarcopenia and sarcopenic obesity are independent adverse prognostic factors in resectable pancreatic ductal adenocarcinoma. PLOS ONE 2019; 14(5): e0215915 doi: 10.1371/journal.pone.0215915
|
| 10 |
Hao-Qi Zhang, Jing Li, Chun-Lu Tan, Yong-Hua Chen, Zhen-Jiang Zheng, Xu-Bao Liu. Neoadjuvant therapy in resectable pancreatic cancer: A promising curative method to improve prognosis. World Journal of Gastrointestinal Oncology 2022; 14(10): 1903-1917 doi: 10.4251/wjgo.v14.i10.1903
|
| 11 |
Toru Nakamura, Toshimichi Asano, Keisuke Okamura, Takahiro Tsuchikawa, Soichi Murakami, Yo Kurashima, Yuma Ebihara, Takehiro Noji, Yoshitsugu Nakanishi, Kimitaka Tanaka, Toshiaki Shichinohe, Satoshi Hirano. A Preoperative Prognostic Scoring System to Predict Prognosis for Resectable Pancreatic Cancer: Who Will Benefit from Upfront Surgery?. Journal of Gastrointestinal Surgery 2019; 23(5): 990 doi: 10.1007/s11605-018-3972-x
|
| 12 |
Elisabeth S. Gruber, Gerd Jomrich, Alexandra Kaider, Michael Gnant, Klaus Sahora, Martin Schindl. The Prognostic Index Independently Predicts Survival in Patients with Pancreatic Ductal Adenocarcinoma Undergoing Resection. Annals of Surgical Oncology 2020; 27(6): 2017 doi: 10.1245/s10434-019-08161-6
|
| 13 |
Xiaotao Dong, Kunlun Wang, Hui Yang, Ruilan Cheng, Yan Li, Yanqi Hou, Jiali Chang, Ling Yuan. The Nomogram predicting the overall survival of patients with pancreatic cancer treated with radiotherapy: a study based on the SEER database and a Chinese cohort. Frontiers in Endocrinology 2023; 14 doi: 10.3389/fendo.2023.1266318
|
| 14 |
Johanna Wennerblom, Pushpa Saksena, Claes Jönsson, Anders Thune. Lymph node 8a as a prognostic marker for poorer prognosis in pancreatic and periampullary carcinoma. Scandinavian Journal of Gastroenterology 2018; 53(2): 225 doi: 10.1080/00365521.2017.1417474
|
| 15 |
Victor Rodrigues, Cristina Dopazo, Elizabeth Pando, Laia Blanco, Mireia Caralt, Concepción Gómez-Gavara, Itxarone Bilbao, María Teresa Salcedo, Joaquim Balsells, Ramon Charco. Is the Involvement of the Hepatic Artery Lymph Node a Poor Prognostic Factor in Pancreatic Adenocarcinoma?. Cirugía Española (English Edition) 2020; 98(4): 204 doi: 10.1016/j.cireng.2020.03.013
|
| 16 |
O. Yu. Usenko, M. Yu. Nychytailo, M. S. Zagriichuk, V. V. Kropelnytskyi, N. E. Klochkova, Yu. V. Nezhentseva, Ya V. Romaniv, O. O. Pidopryhora, D. M. Skrypka. Dynamical lymphadenectomy as a component of multidisciplinary approach while doing operative interventions for pancreatic cancer. Klinicheskaia khirurgiia 2019; 86(7): 42 doi: 10.26779/2522-1396.2019.07.42
|
| 17 |
Roland Andersson, Caj Haglund, Hanna Seppänen, Daniel Ansari. Pancreatic cancer – the past, the present, and the future. Scandinavian Journal of Gastroenterology 2022; 57(10): 1169 doi: 10.1080/00365521.2022.2067786
|
| 18 |
Debora Basile, Carla Corvaja, Riccardo Caccialanza, Giuseppe Aprile. Sarcopenia: looking to muscle mass to better manage pancreatic cancer patients. Current Opinion in Supportive & Palliative Care 2019; 13(4): 279 doi: 10.1097/SPC.0000000000000455
|
| 19 |
Yan-Hui Yang, Jiang-Bo Liu, Yang Gui, Liang-Liang Lei, Shui-Jun Zhang. Relationship between autophagy and perineural invasion, clinicopathological features, and prognosis in pancreatic cancer. World Journal of Gastroenterology 2017; 23(40): 7232-7241 doi: 10.3748/wjg.v23.i40.7232
|
| 20 |
Daisuke Asano, Satoshi Nara, Yoji Kishi, Minoru Esaki, Nobuyoshi Hiraoka, Minoru Tanabe, Kazuaki Shimada. A Single-Institution Validation Study of Lymph Node Staging By the AJCC 8th Edition for Patients with Pancreatic Head Cancer: A Proposal to Subdivide the N2 Category. Annals of Surgical Oncology 2019; 26(7): 2112 doi: 10.1245/s10434-019-07390-z
|